United States · FDA National Drug Code directory
montelukast sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-727_c503ea71-c663-3cfc-e053-2a95a90a9aaa
- Product NDC
- 31722-727
- Form
- TABLET, CHEWABLE
- Composition / generic term
- montelukast sodium
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150527
- Source listing expiry
- 20261231
Source-listed ingredients
- MONTELUKAST — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, CHEWABLE in 1 BOTTLE (31722-727-01) · 31722-727-01
- 1000 TABLET, CHEWABLE in 1 BOTTLE (31722-727-10) · 31722-727-10
- 30 TABLET, CHEWABLE in 1 BOTTLE (31722-727-30) · 31722-727-30
- 10 TABLET, CHEWABLE in 1 BLISTER PACK (31722-727-31) · 31722-727-31
- 100 TABLET, CHEWABLE in 1 CARTON (31722-727-32) · 31722-727-32
- 90 TABLET, CHEWABLE in 1 BOTTLE (31722-727-90) · 31722-727-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →